Liabilities and Equity of Apimeds Pharmaceuticals US, Inc. from 31 Dec 2023 to 30 Sep 2025

Taxonomy & unit: us-gaap: USD
Description: Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
Summary: Apimeds Pharmaceuticals US, Inc. quarterly Liabilities and Equity in USD history and change rate from 31 Dec 2023 to 30 Sep 2025.
Apimeds Pharmaceuticals US, Inc. Liabilities and Equity for the quarter ending 30 Sep 2025 was $9,250,036.
Source SEC data: View on sec.gov

Liabilities and Equity, Quarterly (USD)

Liabilities and Equity, YoY Quarterly Change (%)

Apimeds Pharmaceuticals US, Inc. Quarterly Liabilities and Equity (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q3 2025	$9,250,036			30 Sep 2025	10-Q	12 Nov 2025	2025	Q3
Q2 2025	$10,546,681			30 Jun 2025	10-Q	19 Aug 2025	2025	Q2
Q1 2025	$259,904			31 Mar 2025	10-Q	20 May 2025	2025	Q1
Q4 2024	$13,057	-$409,019	-97%	31 Dec 2024	10-Q	12 Nov 2025	2025	Q3
Q4 2023	$422,076			31 Dec 2023	10-K	15 Apr 2025	2024	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.